Skip to main content

Table 2 Pre-treatment complaints and acute toxicity according to the Common Toxicity Criteria (CTC) and late toxicity according to the Radiation Therapy Oncology Group/European Organization for Research and Treatment of Cancer (RTOG/EORTC) scale

From: High-dose intensity-modulated radiotherapy for prostate cancer using daily fiducial marker-based position verification: acute and late toxicity in 331 patients

Item

Number of patients (%)

 

Grade 0

Grade 1

Grade 2

Grade 3

Grade 4

Pre-treatment (n = 331)

     

   Genitourinary

     

Urinary frequency/urgency

161 (49)

99 (30)

69 (21)

2 (1)

0 (0)

Urinary retention

317 (96)

13 (4)

1 (0.3)

0 (0)

0 (0)

Bladder spasms

328 (99)

3 (1)

0 (0)

0 (0)

0 (0)

Urinary incontinence

318 (96)

13 (4)

0 (0)

0 (0)

0 (0)

Hematuria

324 (98)

6 (2)

1 (0.3)

0 (0)

0 (0)

Dysuria

318 (96)

13 (4)

0 (0)

0 (0)

0 (0)

Overall

150 (45)

108 (33)

71 (22)

2 (1)

0 (0)

   Gastrointestinal

     

Proctitis

306 (92)

19 (6)

6 (2)

0 (0)

0 (0)

Rectal or perirectal pain

328 (99)

3 (1)

0 (0)

0 (0)

0 (0)

Overall

305 (92)

20 (6)

6 (2)

0 (0)

0 (0)

Acute toxicity (n = 331)

     

   Genitourinary

     

Urinary frequency/urgency

25 (8)

154 (47)

144 (44)

8 (2)

0 (0)

Urinary retention

271 (82)

52 (16)

3 (1)

5 (2)

0 (0)

Bladder spasms

309 (94)

18 (5)

4 (1)

0 (0)

0 (0)

Urinary incontinence

305 (92)

23 (7)

3 (1)

0 (0)

0 (0)

Hematuria

317 (96)

7 (2)

6 (2)

1 (0.3)

0 (0)

Dysuria

165 (50)

139 (42)

26 (8)

1 (0.3)

0 (0)

Overall

19 (6)

147 (44)

155 (47)

10 (3)

0 (0)

   Gastrointestinal

     

Proctitis

71 (22)

168 (51)

92 (28)

0 (0)

0 (0)

Rectal or perirectal pain

275 (83)

32 (10)

24 (7)

0 (0)

0 (0)

Overall

63 (19)

169 (51)

99 (30)

0 (0)

0 (0)

   Infection

313 (95)

3 (1)

12 (4)

3 (1)

0 (0)

Late toxicity (n = 320)

     

   Genitourinary

152 (48)

86 (27)

68 (21)

13 (4)

1 (0.3)

   Gastrointestinal

193 (60)

94 (29)

30 (9)

2 (1)

1 (0.3)